🚀 VC round data is live in beta, check it out!
Quantum-Si Valuation Multiples
Discover revenue and EBITDA valuation multiples for Quantum-Si and similar public comparables like Onward Medical, Zepp Health, Affluent Medical, OmniAb and more.
Quantum-Si Overview
About Quantum-Si
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Founded
2013
HQ
Employees
149
Website
Financials (LTM)
EV
$74M
Quantum-Si Financials
Quantum-Si reported last 12-month revenue of $2M and negative EBITDA of ($84M).
In the same LTM period, Quantum-Si generated $891K in gross profit, ($84M) in EBITDA losses, and had net loss of ($101M).
Revenue (LTM)
Quantum-Si P&L
In the most recent fiscal year, Quantum-Si reported revenue of $2M and EBITDA of ($81M).
Quantum-Si expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2M | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | $891K | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | 44% | XXX | 47% | XXX | XXX | XXX |
| EBITDA | ($84M) | XXX | ($81M) | XXX | XXX | XXX |
| EBITDA Margin | (4159%) | XXX | (3313%) | XXX | XXX | XXX |
| EBIT Margin | (5544%) | XXX | (3997%) | XXX | XXX | XXX |
| Net Profit | ($101M) | XXX | ($101M) | XXX | XXX | XXX |
| Net Margin | (5003%) | XXX | (4160%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Quantum-Si Stock Performance
Quantum-Si has current market cap of $233M, and enterprise value of $74M.
Market Cap Evolution
Quantum-Si's stock price is $1.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $74M | $233M | 0.0% | XXX | XXX | XXX | $-0.47 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQuantum-Si Valuation Multiples
Quantum-Si trades at 36.6x EV/Revenue multiple, and (0.9x) EV/EBITDA.
EV / Revenue (LTM)
Quantum-Si Financial Valuation Multiples
As of April 20, 2026, Quantum-Si has market cap of $233M and EV of $74M.
Equity research analysts estimate Quantum-Si's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Quantum-Si has a P/E ratio of (2.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $233M | XXX | $233M | XXX | XXX | XXX |
| EV (current) | $74M | XXX | $74M | XXX | XXX | XXX |
| EV/Revenue | 36.6x | XXX | 30.4x | XXX | XXX | XXX |
| EV/EBITDA | (0.9x) | XXX | (0.9x) | XXX | XXX | XXX |
| EV/EBIT | (0.7x) | XXX | (0.8x) | XXX | XXX | XXX |
| EV/Gross Profit | 83.1x | XXX | 64.2x | XXX | XXX | XXX |
| P/E | (2.3x) | XXX | (2.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Quantum-Si Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Quantum-Si Margins & Growth Rates
Quantum-Si's revenue in the last 12 month grew by 78%.
Quantum-Si's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.7M for the same period.
Quantum-Si's rule of 40 is (8840%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Quantum-Si's rule of X is (8926%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Quantum-Si Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 78% | XXX | (57%) | XXX | XXX | XXX |
| EBITDA Margin | (4159%) | XXX | (3313%) | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (8840%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (8926%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2697% | XXX | 2207% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2687% | XXX | 2207% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 4044% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Quantum-Si Public Comps
See public comps and valuation multiples for other Medical Devices and Life Sciences Tools comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Quantum-Si | XXX | XXX | XXX | XXX | XXX | XXX |
| Onward Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Zepp Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Affluent Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| OmniAb | XXX | XXX | XXX | XXX | XXX | XXX |
| Utah Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Quantum-Si M&A Activity
Quantum-Si acquired XXX companies to date.
Last acquisition by Quantum-Si was on XXXXXXXX, XXXXX. Quantum-Si acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Quantum-Si
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialQuantum-Si Investment Activity
Quantum-Si invested in XXX companies to date.
Quantum-Si made its latest investment on XXXXXXXX, XXXXX. Quantum-Si invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Quantum-Si
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Quantum-Si
| When was Quantum-Si founded? | Quantum-Si was founded in 2013. |
| Where is Quantum-Si headquartered? | Quantum-Si is headquartered in United States. |
| How many employees does Quantum-Si have? | As of today, Quantum-Si has over 149 employees. |
| Who is the CEO of Quantum-Si? | Quantum-Si's CEO is Jeffrey Alan Hawkins. |
| Is Quantum-Si publicly listed? | Yes, Quantum-Si is a public company listed on Nasdaq. |
| What is the stock symbol of Quantum-Si? | Quantum-Si trades under QSI ticker. |
| When did Quantum-Si go public? | Quantum-Si went public in 2021. |
| Who are competitors of Quantum-Si? | Quantum-Si main competitors are Onward Medical, Zepp Health, Affluent Medical, OmniAb. |
| What is the current market cap of Quantum-Si? | Quantum-Si's current market cap is $233M. |
| What is the current revenue of Quantum-Si? | Quantum-Si's last 12 months revenue is $2M. |
| What is the current revenue growth of Quantum-Si? | Quantum-Si revenue growth (NTM/LTM) is 78%. |
| What is the current EV/Revenue multiple of Quantum-Si? | Current revenue multiple of Quantum-Si is 36.6x. |
| Is Quantum-Si profitable? | No, Quantum-Si is not profitable. |
| What is the current EBITDA of Quantum-Si? | Quantum-Si has negative EBITDA and is not profitable. |
| What is Quantum-Si's EBITDA margin? | Quantum-Si's last 12 months EBITDA margin is (4159%). |
| What is the current EV/EBITDA multiple of Quantum-Si? | Current EBITDA multiple of Quantum-Si is (0.9x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.